Aroda, Vanita R., Joseph R. Arulandu, and Anthony J. Cannon.
"Insulin/Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy for the Treatment of Type 2 Diabetes: Are Two Agents Better Than One?." Clinical Diabetes
36.2
(2018):
138-147.
Web. 25 Feb. 2021.
